Drugs & TargetsFree Lynparza approved in the EU as first-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer November 06, 2020Vol.46 No.42
Drugs & TargetsFree Kymriah receives approval for commercial manufacturing in Japan November 06, 2020Vol.46 No.42
Clinical RoundupFree Cancer patients, clinicians find value in electronic real-time symptom reporting November 06, 2020Vol.46 No.42
Clinical RoundupFree Colon cancer surgery performed by highly skilled surgeons improves long-term survival for patients November 06, 2020Vol.46 No.42
Clinical RoundupFree Active surveillance is safe for African Americans with low-risk prostate cancer November 06, 2020Vol.46 No.42
Clinical RoundupFree Nerves keep pancreatic cancer cells from starving, study finds November 06, 2020Vol.46 No.42
Clinical RoundupFree Large-scale cancer proteomics study profiles protein changes in response to drug treatments November 06, 2020Vol.46 No.42
FreeTrials & Tribulations Living with cannabis: The goal of helping cancer patients live in comfort deserves data now November 06, 2020Vol.46 No.42By Dylan M. Zylla
FreeIn Brief Timothy W. Mullett named chair of the Commission on Cancer of the American College of Surgeons November 06, 2020Vol.46 No.42
